Search

everythinglearnresearchcommunity

for

Search:↓

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

The SAAD-41 scale effectively measures the psychosocial impact of alopecia areata.

The Italian version of a relationship scale was adapted for cancer patients, showing some differences from the original and suggesting its use could improve therapy and treatment adherence.

AI improves accuracy and consistency in diagnosing male pattern hair loss.

The Spanish version of the Hair Specific Skindex-29 scale is a reliable and valid way to measure the impact of hair loss on women's quality of life.

A new method accurately measures cell changes in breast cancer.

QMSI effectively maps and quantifies drug distribution in skin tissues.

The updated SALT II tool offers a more precise way to measure scalp hair loss.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Measuring bald patch size can help grade hair loss severity, with photograph-based evaluation being more reliable.

Using both DLQI and Skindex-16 together gives a better understanding of quality of life in skin disease patients.

Centralized imaging provides more accurate and consistent hair loss measurements in alopecia areata.

The technique accurately identifies and evaluates hair follicle structures in skin.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

The tool accurately measures hair count and size on scalps with 79.45% and 68.19% accuracy, respectively.

The new scalp coverage scoring method accurately measures hair loss and growth in men.

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

The DLQI is reliable but may not fully capture the impact of skin conditions on quality of life, especially in emotional and psychological areas.

Computer-aided imaging system helps measure balding area in female pattern hair loss.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

QMSI is a valuable method for studying drug penetration in skin tissues.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Antera 3D® offers more precise and detailed scar assessment than traditional methods.

The new 3D imaging method accurately measures hair surface details quickly.

A reliable severity score for female pattern hair loss was developed and validated.

The Scalp Coverage Scoring method reliably measures hair density from images.

The Spanish HSS-29 scale effectively measures changes in life quality due to female-pattern hair loss.

The new SFS Scale predicts hair transplant difficulty using hair and skin types, with thick skin and coily hair being hardest to work with.

The Spanish version of the Hair Specific Skindex-29 is a reliable tool for measuring quality of life in Spanish-speaking women with hair loss.

Hair shaft miR-221 levels can help detect malignant melanoma.